Error loading player: No playable sources found
2450
Career Planning for APPs (Hep Associations Committee)
Date
May 18, 2024
This product is not available for individual purchase, but it is available as part of the following products:
Full DDW 2024 On Demand Program available now!
SOCIETY: AASLD
Presentation:
| ADDICTION TREATMENT AND HARM REDUCTION IN VIRAL HEPATITIS |
| LIVER TRANSPLANT: POST TRANSPLANT MANAGEMENT FOR THE COMMUNITY PROVIDER |
| EVALUATION AND TREATMENT OF LIVER LESIONS |
| HEPATIC PATHOLOGY FOR THE GI PROVIDER |
| PANEL DISCUSSION |
Moderators
The University of Texas Southwestern Medical Center
Pinnacle Clinical Research
Speakers
Tracks
Related Products
AASLD Presidential Plenary
ASSOCIATION OF GLUCAGON-LIKE PEPTIDE-1 AGONISTS WITH CIRRHOSIS AND HEPATOCELLULAR CANCER IN METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)
Human and Experimental Cholestasis
METABOLIC OUTCOMES AND KEY EFFICACY DATA FROM A PHASE 2 TRIAL EVALUATING COMBINATION OBETICHOLIC ACID AND BEZAFIBRATE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS
Common Consults on Management of ICU Patients with Liver Disease
This session proposed to cover common consults on management of patients with liver disease admitted in ICU seen at community and at academic centers…
